Leukemia Clinical Trials in Minneapolis

Showing 1101-1105 of 1,105 trials

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

NCT00129948

This is a phase 2, single-arm, open-label, multi-center study to establish the safety and efficacy of Troxatyl™ (troxacitabine) administered as a continuous infusion for 5 days to subjects with AML.

Leukemia, Myeloid, Acute

SGX Pharmaceuticals, Inc.211 participantsStarted Jul 2005

La Jolla, California, United States • Los Angeles, California, United States • San Diego, California, United States +17 more locations

COMPLETEDNA< 1 mile

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

NCT00005892

OBJECTIVES: I. Determine the effectiveness of moderate dose cyclophosphamide and radiotherapy in terms of improving survival and reducing the morbidity following allogeneic bone marrow transplantation in patients with myelodysplastic syndrome and acute leukemia related to Fanconi's anemia.

Fanconi's AnemiaMyelodysplastic SyndromesLeukemia, Nonlymphocytic, Acute+1 more

Fairview University Medical CenterStarted Mar 2000

Minneapolis, Minnesota, United States

Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)

Study of Allogeneic Bone Marrow Transplantation Following Cyclophosphamide and Radiotherapy in Patients With Myelodysplastic Syndrome and Acute Leukemia Related to Fanconi's Anemia

Leukemia Trials in Other Cities

Efficacy and Safety of Nipent, Cytoxan and Rituxan in the Treatment of Chronic Lymphocytic Leukemia.

CP-481,715 Nickel Allergy Study.

Safety and Immunogenicity of Recombinant DNA and Adenovirus Expressing L523S Protein in Early Stage Non-Small Cell Lung Cancer

Other Conditions in Minneapolis